English

Tanke Biosciences Corp

EDGAR

TNBI Quarterly report (10-Q) · filed 2013-11-14

28 filing records in this dataset, filed from 2009-03-25 to 2013-11-14. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

6.04 million USD

2013 Q3 · USD

Exact inputs and evidence

Revenue: 6041004 USD Source

Operating margin

-8.78%

2013 Q3 · %

Exact inputs and evidence

Operating Income: -530338 USD Source
Revenue: 6041004 USD Source

Operating cash flow

1.61 million USD

2013 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: 1375956 USD Source
Operating Cash Flow: -235772 USD Source

Free cash flow

538 thousand USD

2013 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: 1375956 USD Source
Operating Cash Flow: -235772 USD Source
Capital Expenditure: 2433181 USD Source
Capital Expenditure: 1359529 USD Source

Cash and cash equivalents: 5.05 million USD 2013-09-30 Source
Exact value

5053700 USD
Long-term debt including current maturities: 1.87 million USD 2013-09-30 Source
Exact value

1872325 USD
Shares outstanding: 13.3 million shares 2013-09-30 Source
Exact value

13324083 shares

Reported share-count change

0.00% · 0 shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

13324083 shares · 2012-09-30· Source
13324083 shares · 2013-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Capital expenditure

2.49 million USD

2012-10-01 – 2013-09-30

Exact inputs and evidence

Capital expenditure: 856361 USD · 2012-01-01 – 2012-12-31 Source
Capital expenditure: 799922 USD · 2012-01-01 – 2012-09-30 Source
Capital expenditure: 746033 USD · 2013-01-01 – 2013-03-31 Source
Capital expenditure: 1359529 USD · 2013-01-01 – 2013-06-30 Source
Capital expenditure: 746033 USD · 2013-01-01 – 2013-03-31 Source
Capital expenditure: 2433181 USD · 2013-01-01 – 2013-09-30 Source
Capital expenditure: 1359529 USD · 2013-01-01 – 2013-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2013-11-14.

Financial data available through: 2012-12-31.

Coverage by financial measure

Revenue: 5 of 11 periods available· newest 2012-12-31
Operating income: 5 of 11 periods available· newest 2012-12-31
Net income: 5 of 11 periods available· newest 2012-12-31
Operating cash flow: 5 of 11 periods available· newest 2012-12-31
Capital expenditure: 3 of 11 periods available· newest 2012-12-31
Total assets: 5 of 11 periods available· newest 2012-12-31
Total liabilities: 5 of 11 periods available· newest 2012-12-31
Current assets: 5 of 11 periods available· newest 2012-12-31
Current liabilities: 5 of 11 periods available· newest 2012-12-31
Cash and cash equivalents: 5 of 11 periods available· newest 2012-12-31
Long-term debt including current maturities: 3 of 11 periods available· newest 2012-12-31
Shares outstanding: 3 of 11 periods available· newest 2012-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+19.8%

Prior period

USD 23.83 million

2011-01-01 – 2011-12-31
Current period

USD 28.56 million

2012-01-01 – 2012-12-31

Exact inputs and evidence

28561829 − 23832727 = 4729102 USD

23832727 USD · 2011-01-01 – 2011-12-31
Inspect prior input Prior source
28561829 USD · 2012-01-01 – 2012-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Tanke Biosciences Corp · 2012-12-31 Tanke Biosciences Corp (edgar:1452011) Year-over-year change in Revenue: 4729102 USD Concept: fundies:Revenue Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T09:09:15Z Snapshot: d629cff498918229b8ec7c383c2893f750d29235c68b2af82428530dbb29da5e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1452011?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 28561829 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1452011/000121390013001814/tnbi-20121231.xml#81792 Filing: 000121390013001814 Input fundies:Revenue: 23832727 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1452011/000121390013001814/tnbi-20121231.xml#80936 Filing: 000121390013001814
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 2.93 million

Prior period

−USD 3.14 million

2011-01-01 – 2011-12-31
Current period

−USD 210,247

2012-01-01 – 2012-12-31

Exact inputs and evidence

-210247 − -3136094 = 2925847 USD

-3136094 USD · 2011-01-01 – 2011-12-31
Inspect prior input Prior source
-210247 USD · 2012-01-01 – 2012-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Tanke Biosciences Corp · 2012-12-31 Tanke Biosciences Corp (edgar:1452011) Year-over-year change in Net income: 2925847 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T09:09:15Z Snapshot: d629cff498918229b8ec7c383c2893f750d29235c68b2af82428530dbb29da5e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1452011?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -210247 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1452011/000121390013001814/tnbi-20121231.xml#88859 Filing: 000121390013001814 Input fundies:NetIncome: -3136094 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1452011/000121390013001814/tnbi-20121231.xml#88739 Filing: 000121390013001814
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-132.4%

Prior period

USD 3.65 million

2011-01-01 – 2011-12-31
Current period

−USD 1.18 million

2012-01-01 – 2012-12-31

Exact inputs and evidence

-1184097 − 3653141 = -4837238 USD

3653141 USD · 2011-01-01 – 2011-12-31
Inspect prior input Prior source
-1184097 USD · 2012-01-01 – 2012-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Tanke Biosciences Corp · 2012-12-31 Tanke Biosciences Corp (edgar:1452011) Year-over-year change in Operating cash flow: -4837238 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T09:09:15Z Snapshot: d629cff498918229b8ec7c383c2893f750d29235c68b2af82428530dbb29da5e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1452011?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -1184097 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1452011/000121390013001814/tnbi-20121231.xml#96624 Filing: 000121390013001814 Input fundies:OperatingCashFlow: 3653141 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1452011/000121390013001814/tnbi-20121231.xml#96407 Filing: 000121390013001814
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+22.2%

Prior period

USD 701,022

2011-01-01 – 2011-12-31
Current period

USD 856,361

2012-01-01 – 2012-12-31

Exact inputs and evidence

856361 − 701022 = 155339 USD

701022 USD · 2011-01-01 – 2011-12-31
Inspect prior input Prior source
856361 USD · 2012-01-01 – 2012-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Tanke Biosciences Corp · 2012-12-31 Tanke Biosciences Corp (edgar:1452011) Year-over-year change in Capital expenditure: 155339 USD Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T09:09:15Z Snapshot: d629cff498918229b8ec7c383c2893f750d29235c68b2af82428530dbb29da5e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1452011?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 856361 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1452011/000121390013001814/tnbi-20121231.xml#97383 Filing: 000121390013001814 Input fundies:CapitalExpenditure: 701022 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1452011/000121390013001814/tnbi-20121231.xml#97207 Filing: 000121390013001814
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2012 2012-01-01 – 2012-12-31

Revenue USD 28.56 million 100% of revenue
Operating costs Derived USD 24.03 million 84% of revenue
Operating income USD 4.53 million 16% of revenue
Tax, interest and other Derived USD 4.74 million 17% of revenue
Net income −USD 210,247 −0.7% of revenue

Cash

Operating cash flow −USD 1.18 million −4.1% of revenue
Capital expenditure USD 856,361 3% of revenue
Free cash flow Derived −USD 2.04 million −7.1% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2008 Not shown: operating income or net income is not reported.
2009 Not shown: operating income or net income is not reported.
2010 14%78%
2011 Net loss: net income was −13% of revenue.
2012 Net loss: net income was −0.7% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2008 2008-01-01 – 2008-12-31	0	17937 Derived	-17937	581 Derived	-18518	Unavailable	Source 2008-01-01 – 2008-12-31: 0 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: -17937 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: -18518 USD Inspect Net Income Open source 2008-01-01 – 2008-12-31: -13268 USD Inspect Operating Cash Flow Open source
2009 2009-01-01 – 2009-12-31	0	19831 Derived	-19831	1834 Derived	-21665	Unavailable	Source 2009-01-01 – 2009-12-31: 0 USD Inspect Revenue Open source 2009-01-01 – 2009-12-31: -19831 USD Inspect Operating Income Open source 2009-01-01 – 2009-12-31: -21665 USD Inspect Net Income Open source 2009-01-01 – 2009-12-31: -13415 USD Inspect Operating Cash Flow Open source
2010 2010-01-01 – 2010-12-31	20097784	15723675 Derived	4374109	1635854 Derived	2738255	4308917 Derived	Source 2010-01-01 – 2010-12-31: 20097784 USD Inspect Revenue Open source 2010-01-01 – 2010-12-31: 4374109 USD Inspect Operating Income Open source 2010-01-01 – 2010-12-31: 2738255 USD Inspect Net Income Open source 2010-01-01 – 2010-12-31: 4384988 USD Inspect Operating Cash Flow Open source 2010-01-01 – 2010-12-31: 76071 USD Inspect Capital Expenditure Open source
2011 2011-01-01 – 2011-12-31	23832727	22093914 Derived	1738813	4874907 Derived	-3136094	2952119 Derived	Source 2011-01-01 – 2011-12-31: 23832727 USD Inspect Revenue Open source 2011-01-01 – 2011-12-31: 1738813 USD Inspect Operating Income Open source 2011-01-01 – 2011-12-31: -3136094 USD Inspect Net Income Open source 2011-01-01 – 2011-12-31: 3653141 USD Inspect Operating Cash Flow Open source 2011-01-01 – 2011-12-31: 701022 USD Inspect Capital Expenditure Open source
2012 2012-01-01 – 2012-12-31	28561829	24030210 Derived	4531619	4741866 Derived	-210247	-2040458 Derived	Source 2012-01-01 – 2012-12-31: 28561829 USD Inspect Revenue Open source 2012-01-01 – 2012-12-31: 4531619 USD Inspect Operating Income Open source 2012-01-01 – 2012-12-31: -210247 USD Inspect Net Income Open source 2012-01-01 – 2012-12-31: -1184097 USD Inspect Operating Cash Flow Open source 2012-01-01 – 2012-12-31: 856361 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 28.6M 2012

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20082008-12-31	Revenue	0	Revenue: 0 Open source
20092009-12-31	Revenue	0	Revenue: 0 Open source
20102010-12-31	Revenue	20097784	Revenue: 20097784 Open source
20112011-12-31	Revenue	23832727	Revenue: 23832727 Open source
20122012-12-31	Revenue	28561829	Revenue: 28561829 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

19.8% 2012

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20082008-12-31	Year over year	No prior comparable period	Revenue: 0 Open source
20092009-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20102010-12-31	Year over year	No prior comparable period	Revenue: 20097784 Open source Revenue: 0 Open source
20112011-12-31	Year over year	18.6%	Revenue: 23832727 Open source Revenue: 20097784 Open source
20122012-12-31	Year over year	19.8%	Revenue: 28561829 Open source Revenue: 23832727 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 15.9% 2012

Net margin -0.7% 2012

Free cash flow margin -7.1% 2012

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20082008-12-31	Operating margin	Not reported	Operating Income: -17937 Open source Revenue: 0 Open source
20092009-12-31	Operating margin	Not reported	Operating Income: -19831 Open source Revenue: 0 Open source
20102010-12-31	Operating margin	21.8%	Operating Income: 4374109 Open source Revenue: 20097784 Open source
20112011-12-31	Operating margin	7.3%	Operating Income: 1738813 Open source Revenue: 23832727 Open source
20122012-12-31	Operating margin	15.9%	Operating Income: 4531619 Open source Revenue: 28561829 Open source
20082008-12-31	Net margin	Not reported	Net Income: -18518 Open source Revenue: 0 Open source
20092009-12-31	Net margin	Not reported	Net Income: -21665 Open source Revenue: 0 Open source
20102010-12-31	Net margin	13.6%	Net Income: 2738255 Open source Revenue: 20097784 Open source
20112011-12-31	Net margin	-13.2%	Net Income: -3136094 Open source Revenue: 23832727 Open source
20122012-12-31	Net margin	-0.7%	Net Income: -210247 Open source Revenue: 28561829 Open source
20082008-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -13268 Open source
20092009-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -13415 Open source
20102010-12-31	Free cash flow margin	21.4%	Revenue: 20097784 Open source Operating Cash Flow: 4384988 Open source Capital Expenditure: 76071 Open source
20112011-12-31	Free cash flow margin	12.4%	Revenue: 23832727 Open source Operating Cash Flow: 3653141 Open source Capital Expenditure: 701022 Open source
20122012-12-31	Free cash flow margin	-7.1%	Revenue: 28561829 Open source Operating Cash Flow: -1184097 Open source Capital Expenditure: 856361 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -1.2M 2012

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20082008-12-31	Operating cash flow	-13268	Operating Cash Flow: -13268 Open source
20092009-12-31	Operating cash flow	-13415	Operating Cash Flow: -13415 Open source
20102010-12-31	Operating cash flow	4384988	Operating Cash Flow: 4384988 Open source
20112011-12-31	Operating cash flow	3653141	Operating Cash Flow: 3653141 Open source
20122012-12-31	Operating cash flow	-1184097	Operating Cash Flow: -1184097 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -2M 2012

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20082008-12-31	Free cash flow	Unavailable	Operating Cash Flow: -13268 Open source
20092009-12-31	Free cash flow	Unavailable	Operating Cash Flow: -13415 Open source
20102010-12-31	Free cash flow	4308917	Operating Cash Flow: 4384988 Open source Capital Expenditure: 76071 Open source
20112011-12-31	Free cash flow	2952119	Operating Cash Flow: 3653141 Open source Capital Expenditure: 701022 Open source
20122012-12-31	Free cash flow	-2040458	Operating Cash Flow: -1184097 Open source Capital Expenditure: 856361 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

44.8% 2012

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20082008-12-31	Liabilities / assets	2,308.1%	Total Liabilities: 17311 Open source Total Assets: 750 Open source
20092009-12-31	Liabilities / assets	Not reported	Total Liabilities: 32226 Open source Total Assets: 0 Open source
20102010-12-31	Liabilities / assets	22.1%	Total Liabilities: 2932483 Open source Total Assets: 13266629 Open source
20112011-12-31	Liabilities / assets	36.3%	Total Liabilities: 9032703 Open source Total Assets: 24887006 Open source
20122012-12-31	Liabilities / assets	44.8%	Total Liabilities: 12926200 Open source Total Assets: 28849160 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.85× 2012

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20082008-12-31	Current assets / current liabilities	0.04×	Current Assets: 750 Open source Current Liabilities: 17311 Open source
20092009-12-31	Current assets / current liabilities	0×	Current Assets: 0 Open source Current Liabilities: 32226 Open source
20102010-12-31	Current assets / current liabilities	3.19×	Current Assets: 7673199 Open source Current Liabilities: 2405999 Open source
20112011-12-31	Current assets / current liabilities	5.33×	Current Assets: 18913734 Open source Current Liabilities: 3545981 Open source
20122012-12-31	Current assets / current liabilities	1.85×	Current Assets: 22367919 Open source Current Liabilities: 12095685 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2008 2008-01-01 – 2008-12-31	−USD 18,518 Exact value Exact value: -18518 USD 2008-01-01 – 2008-12-31: -18518 USD Inspect Net Income Open source Share or cite Citation for Net Income · Tanke Biosciences Corp · 2008-12-31 Tanke Biosciences Corp (edgar:1452011) Net Income: -18518 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T09:09:15Z Snapshot: d629cff498918229b8ec7c383c2893f750d29235c68b2af82428530dbb29da5e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1452011/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -18518 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1452011/0000931731-11-000022.txt#3049 The citation records this snapshot. The page link may show a newer release later.	−USD 13,268 Exact value Exact value: -13268 USD 2008-01-01 – 2008-12-31: -13268 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Tanke Biosciences Corp · 2008-12-31 Tanke Biosciences Corp (edgar:1452011) Operating Cash Flow: -13268 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T09:09:15Z Snapshot: d629cff498918229b8ec7c383c2893f750d29235c68b2af82428530dbb29da5e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1452011/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13268 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1452011/0000931731-11-000022.txt#3221 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2009 2009-01-01 – 2009-12-31	−USD 21,665 Exact value Exact value: -21665 USD 2009-01-01 – 2009-12-31: -21665 USD Inspect Net Income Open source Share or cite Citation for Net Income · Tanke Biosciences Corp · 2009-12-31 Tanke Biosciences Corp (edgar:1452011) Net Income: -21665 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T09:09:15Z Snapshot: d629cff498918229b8ec7c383c2893f750d29235c68b2af82428530dbb29da5e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1452011/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: -21665 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1452011/0001193805-11-000601.txt#8170 The citation records this snapshot. The page link may show a newer release later.	−USD 13,415 Exact value Exact value: -13415 USD 2009-01-01 – 2009-12-31: -13415 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Tanke Biosciences Corp · 2009-12-31 Tanke Biosciences Corp (edgar:1452011) Operating Cash Flow: -13415 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T09:09:15Z Snapshot: d629cff498918229b8ec7c383c2893f750d29235c68b2af82428530dbb29da5e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1452011/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13415 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1452011/0001193805-11-000601.txt#8328 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2010 2010-01-01 – 2010-12-31	USD 2.74 million Exact value Exact value: 2738255 USD 2010-01-01 – 2010-12-31: 2738255 USD Inspect Net Income Open source Share or cite Citation for Net Income · Tanke Biosciences Corp · 2010-12-31 Tanke Biosciences Corp (edgar:1452011) Net Income: 2738255 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T09:09:15Z Snapshot: d629cff498918229b8ec7c383c2893f750d29235c68b2af82428530dbb29da5e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1452011/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: 2738255 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1452011/000119380512000689/tnbi-20111231.xml#44194 Filing: 000119380512000689 The citation records this snapshot. The page link may show a newer release later.	USD 4.38 million Exact value Exact value: 4384988 USD 2010-01-01 – 2010-12-31: 4384988 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Tanke Biosciences Corp · 2010-12-31 Tanke Biosciences Corp (edgar:1452011) Operating Cash Flow: 4384988 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T09:09:15Z Snapshot: d629cff498918229b8ec7c383c2893f750d29235c68b2af82428530dbb29da5e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1452011/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 4384988 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1452011/000119380512000689/tnbi-20111231.xml#51926 Filing: 000119380512000689 The citation records this snapshot. The page link may show a newer release later.	USD 76,071 Exact value Exact value: 76071 USD 2010-01-01 – 2010-12-31: 76071 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Tanke Biosciences Corp · 2010-12-31 Tanke Biosciences Corp (edgar:1452011) Capital Expenditure: 76071 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T09:09:15Z Snapshot: d629cff498918229b8ec7c383c2893f750d29235c68b2af82428530dbb29da5e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1452011/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 76071 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1452011/000119380512000689/tnbi-20111231.xml#57541 Filing: 000119380512000689 The citation records this snapshot. The page link may show a newer release later.	USD 4.31 million Calculation and evidence 4384988 − 76071 USD Exact free cash flow: 4308917 USD 2010-01-01 – 2010-12-31: 4384988 USD · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 76071 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Tanke Biosciences Corp · 2010-12-31 Tanke Biosciences Corp (edgar:1452011) Free cash flow: 4308917 USD Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T09:09:15Z Snapshot: d629cff498918229b8ec7c383c2893f750d29235c68b2af82428530dbb29da5e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1452011?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 4384988 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1452011/000119380512000689/tnbi-20111231.xml#51926 Filing: 000119380512000689 Input fundies:CapitalExpenditure: 76071 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1452011/000119380512000689/tnbi-20111231.xml#57541 Filing: 000119380512000689 The citation records this snapshot. The page link may show a newer release later.
2011 2011-01-01 – 2011-12-31	−USD 3.14 million Exact value Exact value: -3136094 USD 2011-01-01 – 2011-12-31: -3136094 USD Inspect Net Income Open source Share or cite Citation for Net Income · Tanke Biosciences Corp · 2011-12-31 Tanke Biosciences Corp (edgar:1452011) Net Income: -3136094 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T09:09:15Z Snapshot: d629cff498918229b8ec7c383c2893f750d29235c68b2af82428530dbb29da5e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1452011/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3136094 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1452011/000121390013001814/tnbi-20121231.xml#88739 Filing: 000121390013001814 The citation records this snapshot. The page link may show a newer release later.	USD 3.65 million Exact value Exact value: 3653141 USD 2011-01-01 – 2011-12-31: 3653141 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Tanke Biosciences Corp · 2011-12-31 Tanke Biosciences Corp (edgar:1452011) Operating Cash Flow: 3653141 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T09:09:15Z Snapshot: d629cff498918229b8ec7c383c2893f750d29235c68b2af82428530dbb29da5e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1452011/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 3653141 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1452011/000121390013001814/tnbi-20121231.xml#96407 Filing: 000121390013001814 The citation records this snapshot. The page link may show a newer release later.	USD 701,022 Exact value Exact value: 701022 USD 2011-01-01 – 2011-12-31: 701022 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Tanke Biosciences Corp · 2011-12-31 Tanke Biosciences Corp (edgar:1452011) Capital Expenditure: 701022 USD Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T09:09:15Z Snapshot: d629cff498918229b8ec7c383c2893f750d29235c68b2af82428530dbb29da5e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1452011/explain?concept=fundies%3ACapitalExpenditure&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 701022 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1452011/000121390013001814/tnbi-20121231.xml#97207 Filing: 000121390013001814 The citation records this snapshot. The page link may show a newer release later.	USD 2.95 million Calculation and evidence 3653141 − 701022 USD Exact free cash flow: 2952119 USD 2011-01-01 – 2011-12-31: 3653141 USD · Inspect Operating Cash Flow · Source 2011-01-01 – 2011-12-31: 701022 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Tanke Biosciences Corp · 2011-12-31 Tanke Biosciences Corp (edgar:1452011) Free cash flow: 2952119 USD Concept: free-cash-flow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T09:09:15Z Snapshot: d629cff498918229b8ec7c383c2893f750d29235c68b2af82428530dbb29da5e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1452011?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 3653141 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1452011/000121390013001814/tnbi-20121231.xml#96407 Filing: 000121390013001814 Input fundies:CapitalExpenditure: 701022 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1452011/000121390013001814/tnbi-20121231.xml#97207 Filing: 000121390013001814 The citation records this snapshot. The page link may show a newer release later.
2012 2012-01-01 – 2012-12-31	−USD 210,247 Exact value Exact value: -210247 USD 2012-01-01 – 2012-12-31: -210247 USD Inspect Net Income Open source Share or cite Citation for Net Income · Tanke Biosciences Corp · 2012-12-31 Tanke Biosciences Corp (edgar:1452011) Net Income: -210247 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T09:09:15Z Snapshot: d629cff498918229b8ec7c383c2893f750d29235c68b2af82428530dbb29da5e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1452011/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: -210247 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1452011/000121390013001814/tnbi-20121231.xml#88859 Filing: 000121390013001814 The citation records this snapshot. The page link may show a newer release later.	−USD 1.18 million Exact value Exact value: -1184097 USD 2012-01-01 – 2012-12-31: -1184097 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Tanke Biosciences Corp · 2012-12-31 Tanke Biosciences Corp (edgar:1452011) Operating Cash Flow: -1184097 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T09:09:15Z Snapshot: d629cff498918229b8ec7c383c2893f750d29235c68b2af82428530dbb29da5e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1452011/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1184097 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1452011/000121390013001814/tnbi-20121231.xml#96624 Filing: 000121390013001814 The citation records this snapshot. The page link may show a newer release later.	USD 856,361 Exact value Exact value: 856361 USD 2012-01-01 – 2012-12-31: 856361 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Tanke Biosciences Corp · 2012-12-31 Tanke Biosciences Corp (edgar:1452011) Capital Expenditure: 856361 USD Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T09:09:15Z Snapshot: d629cff498918229b8ec7c383c2893f750d29235c68b2af82428530dbb29da5e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1452011/explain?concept=fundies%3ACapitalExpenditure&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 856361 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1452011/000121390013001814/tnbi-20121231.xml#97383 Filing: 000121390013001814 The citation records this snapshot. The page link may show a newer release later.	−USD 2.04 million Calculation and evidence -1184097 − 856361 USD Exact free cash flow: -2040458 USD 2012-01-01 – 2012-12-31: -1184097 USD · Inspect Operating Cash Flow · Source 2012-01-01 – 2012-12-31: 856361 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Tanke Biosciences Corp · 2012-12-31 Tanke Biosciences Corp (edgar:1452011) Free cash flow: -2040458 USD Concept: free-cash-flow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T09:09:15Z Snapshot: d629cff498918229b8ec7c383c2893f750d29235c68b2af82428530dbb29da5e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1452011?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1184097 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1452011/000121390013001814/tnbi-20121231.xml#96624 Filing: 000121390013001814 Input fundies:CapitalExpenditure: 856361 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1452011/000121390013001814/tnbi-20121231.xml#97383 Filing: 000121390013001814 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

28 filings · 1,308 latest values · 1,308 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001452011, 1452011, TNBI, edgar:1452011, tnbi

Also known as GREYHOUND COMMISSARY, INC., Tanke Biosciences Corp

Tanke Biosciences Corp

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Capital expenditure

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2012 2012-01-01 – 2012-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation